Replies to post #295575 on Avid Bioservices Inc (CDMO)

[biopharm]

So the pper gets to tell the Nasdaq everything huh.

Violate SEC rules and also all the NDAs they supposedly have. So the can keep their Nasdaq listing without doing a RS.

You should probably read about all the puzzle pieces and know Nasdaq regulations and Delaware laws and SEC rules....some TRUMP others

Maybe if there are nondisclosures with a party with Big Ties to a certain Big Pharma that would serve them best to have a reverse split.... and it could be that Peregrine gets forced into something that they really did not want to do as a result of time delays and now they think long and hard of Delaware laws ( as evident by them saying that a reverse split IS NOT in the best interest of Peregrine shareholders) so now here we are....

Nasdaq rules at Hearings Panel says non disclosures WOULD BE ALLOWED and how in the hell can they not allow an extension when its the very rules of nondisclosures that is stalling the price increase to PROPER VALUATION....

Now back to Xencor undisclosed Targets in their pipeline and damn...lots of undisclosures these days....that when all breaks open... PPHM breaks wide open as well